Huisinga, W
55  results:
Search for persons X
?
1

P072 Evaluation of dosing strategies of anti-TNFα monoclona..:

Démaris, A ; Grišić, A M ; Huisinga, W..
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S171-S172 , 2020
 
?
2

P485 Dosing infliximab in Crohn's disease: Is adjustment fo..:

Grisic, A.-M. ; Huisinga, W. ; Reinisch, W..
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S325-S326 , 2017
 
?
3

Translational Pharmacometric Evaluation of Typical Antibiot..:

Wicha, SG ; Huisinga, W ; Kloft, C
CPT: Pharmacometrics & Systems Pharmacology.  6 (2017)  8 - p. 512-522 , 2017
 
?
 
?
5

Modeling Interindividual Variability in Physiologically Bas..:

Huisinga, W ; Solms, A ; Fronton, L.
CPT: Pharmacometrics & Systems Pharmacology.  1 (2012)  9 - p. 1-10 , 2012
 
?
6

Adaptive Discrete Galerkin Methods Applied to the Chemical ..:

Deuflhard, P. ; Huisinga, W. ; Jahnke, T..
SIAM Journal on Scientific Computing.  30 (2008)  6 - p. 2990-3011 , 2008
 
?
7

Hybrid stochastic and deterministic simulations of calcium ..:

, In: Biophysical journal / ed. by the Biophysical Society
Rüdiger, S. ; Shuai, J. W. ; Huisinga, W..... (2007)  6 - p. 1847-1857
Copies:  Zentrale: z bcp 700 jc/125; Zentrale:Magazin Zs fb 8125
 
?
8

Identification of almost invariant aggregates in reversible..:

Deuflhard, P. ; Huisinga, W. ; Fischer, A..
Linear Algebra and its Applications.  315 (2000)  1-3 - p. 39-59 , 2000
 
?
9

A Direct Approach to Conformational Dynamics Based on Hybri..:

Schütte, Ch ; Fischer, A ; Huisinga, W.
Journal of Computational Physics.  151 (1999)  1 - p. 146-168 , 1999
 
?
10

Insights in the maturational processes influencing hydrocor..:

Michelet, R ; Bindellini, D ; Melin, J...
https://eprints.whiterose.ac.uk/195792/1/fphar-13-1090554.pdf.  , 2023
 
?
11

Model-Informed target morning 17α-hydroxyprogesterone conce..:

Stachanow, V ; Neumann, U ; Blankenstein, O...
https://eprints.whiterose.ac.uk/198365/1/pharmaceuticals-16-00464-v2.pdf.  , 2023
 
?
13

High-Dosage Fosfomycin Results in Adequate Plasma and Targe..:

Busse, D ; Simon, P ; Petroff, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211401/.  , 2022
 
?
14

Reducing systems biology models to derive mechanism-based d..:

Falkenhagen, U ; Knöchel, J ; Kloft, C.
Hamberg AK, Dahl ML, Barban M, Scordo MG, Wadelius M, Pengo V, Padrini R, Jonsson EN. A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy. Clin Pharmacol Ther. 2007 Apr;81(4):529-38. DOI:10.1038/sj.clpt.6100084.  , 2021
 
?
15

Obesity Alters Endoxifen Plasma Levels in Young Breast Canc..:

Mueller-Schoell, A ; Klopp-Schulze, L ; Schroth, W...
Mueller-Schoell , A , Klopp-Schulze , L , Schroth , W , Murdter , T , Michelet , R , Brauch , H , Huisinga , W , Joerger , M , Neven , P , Koolen , S , Mathijssen , R , Copson , E , Eccles , D , Chen , S , Chowbay , B , Tfayli , A , Zgheib , NK , Schwab , M & Kloft , C 2020 , ' Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach ' , Clinical Pharmacology & Therapeutics , vol. 108 , no. 3 , pp. 661-670 . https://doi.org/10.1002/cpt.1960.  , 2020
 
1-15